New possibilities of therapy for advanced, metastatic breast cancer

Journal Title: OncoReview - Year 2013, Vol 3, Issue 1

Abstract

Despite improving screening methods, diagnosis of early breast cancers, new therapies the prognosis in breast cancer remains poor. Advanced, metastatic breast cancer is an incurable, persistent disease. Hormonotherapy is the main treatment of receptor positive breast cancer patients. Till now in case of hormone resistant disease chemotherapy was the only choice nowadays there is possibility to use combination of endocrine and targeted therapy, the mTOR inhibitor everolimus. In HER2 receptor positive breast cancer therapy with trasuzumab improved treatment results. Despite many new treatment methods there is still need for new therapies which could improve the patients outcome.

Authors and Affiliations

Małgorzata Kuc-Rajca, Anna Walaszkowska-Czyż

Keywords

Related Articles

Cisplatin-induced cardiotoxicity – two case reports

Cisplatin has been used for over 40 years in various cancer chemotherapies. Toxicity induced by cisplatin-based therapeutic regimens include gastrointestinal toxicity, myelotoxicity, neurotoxicity, ototoxicity and nephro...

Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EURTAC study results

Between 2010–2011 the first EGFR thyrosine kinase inhibitor (EGFR TKI) – gefitinib, was registered in many countries in I line of treatment in patients with advanced and locally advanced non-small cell lung cancer (NSCLC...

Compliance, adherence, persistence – przyczyny i konsekwencje niestosowania się pacjentów do zaleceń terapeutycznych

Nieprzestrzeganie zaleceń terapeutycznych znajduje się wśród najpoważniejszych problemów zdrowotnych ludzkości. Zostało uznane za jedną z najważniejszych przeszkód w osiąganiu korzyści z terapii opartej na aktualnej wied...

Lymphoma-induced hemophagocytic lymphohistiocytosis (HLH)– case report

Hemophagocytic lymphohistiocytosis (HLH) is a rare (especially in adults) syndrome in which hyperinflammation leads to fever, hepatosplenomegaly, pancytopenia and when untreated leads to death. Characteristic laboratory...

Download PDF file
  • EP ID EP53205
  • DOI -
  • Views 187
  • Downloads 0

How To Cite

Małgorzata Kuc-Rajca, Anna Walaszkowska-Czyż (2013). New possibilities of therapy for advanced, metastatic breast cancer. OncoReview, 3(1), -. https://europub.co.uk/articles/-A-53205